Key facts
- NanoViricides Inc. filed Form S-3 with the SEC on June 5.
- The filing registers securities for potential future offerings.
- Form S-3 allows companies to register securities for future sale without a new filing for each offering.
NanoViricides Inc. has filed a Form S-3 with the U.S. Securities and Exchange Commission on June 5. This type of filing is typically used by companies to register securities they intend to offer for sale in the future. The Form S-3 allows a company to "shelf" its securities, meaning it can register them now and then sell them over time as market conditions or its capital needs dictate, without needing to file a new registration statement each time. This filing indicates NanoViricides Inc. is preparing for potential future capital raises through the sale of its securities.